EFPIA Newsletter 02 March 2017

2 March 2017

News     02 March 2017 020317 EFPIA, EUCOPE and EuropaBio welcome the Publication of the European Commission’s Study... The associations call for policy measures that preserve patients’ safety and the integrity of the EU regulatory regime... Read more →         01 March 2017 170301 New project: success and failure in the development and commercialisation of ATMP products... A Lygature’s project Read more →

Events calendar     17 MAY 2017   China/EU Pharmaceutical Industry Forum Shanghai, China A workshop jointly organised by EFPIA and CPIA Learn more →       04 APR 2017   20170404 Biovision World Life Science Forum Lyon, France This year, the forum will welcome major players from the health sector representing each step of the value chain with... Learn more →

	01 MAY 2017			13th Annual Meeting of ISMPP - Global Publication Practices: Advancing Ethics and... National Harbor, Maryland, USA Global Publication Practices: Advancing Ethics and Scientific Integrity in an Era of Data-Sharing Learn more →

	15 MAY 2017			11th International Pharmaceutical and Medical Device Compliance Congress Lisbon, Portugal Learn more →

What we are reading IMI Newsletter 02 March 2017  (IMI) Read more → Commission outlines 5 scenarios for future of EU in white paper 02 March 2017  (POLITICO) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe